'a Phase 3, Randomized, Double-Blind Study of Tivantinib (Arq 197) in Subjects With Met Diagnostic-High.... Grant uri icon

total award amount

  • 38605.59

direct costs

  • 30884.47

sponsor award ID

  • ARQ197-A-U303

local award ID

  • 00087595